Insiders LB Pharmaceuticals Inc

Equities

Real-time Estimate Cboe BZX Other stock markets 02:09:12 2026-03-13 pm EDT			5-day change	1st Jan Change
25.78 ^USD	+3.39%		+10.18%	+17.70%

Mar. 10	LB Pharmaceuticals Inc Approves the Promotion of Gad Soffer, the Chief Business Officer, to the Position of Chief Operating and Business Officer, Effective March 4, 2026	CI
Mar. 09	Certain Class A Common Stock Warrants of LB Pharmaceuticals Inc are subject to a Lock-Up Agreement Ending on 10-MAR-2026.	CI

Mar. 10	LB Pharmaceuticals Inc Approves the Promotion of Gad Soffer, the Chief Business Officer, to the Position of Chief Operating and Business Officer, Effective March 4, 2026	CI
Mar. 09	LB Pharmaceuticals Inc Appoints Robert Lenz, M.D., Ph.D. to Board of Directors	CI
Jan. 21	LB Pharmaceuticals Inc Appoints Minako Pazdera as General Counsel	CI
Jan. 06	LB Pharmaceuticals, Inc Announces Appointment of Ellen Rose as Senior Vice President, Corporate Affairs and Lindsay Beaupre as Senior Vice President, People and Culture	CI
Nov. 12	LB Pharmaceuticals, Inc Appoints Kaya Pai Panandiker as Chief Commercial Officer, Effective as of November 10, 2025	CI
25-10-14	LB Pharmaceuticals Inc Appoints James Rawls as Senior Vice President of Regulatory Affairs	CI
25-09-25	LB Pharmaceuticals Inc Announces Board Appointments, Effective September 10, 2025	CI